Department of Radiation Oncology, Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Australia; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Australia; Alfred Health Radiation Oncology Services, Australia; School of Clinical Medicine, University of Cambridge, UK; Department of Epidemiology and Preventive Medicine, Monash University, Australia.
Cancer Epidemiology Division, Cancer Council Victoria, Australia; Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Australia; Precision Medicine, School of Clinical Sciences, Monash Health, Monash University, Australia.
Clin Genitourin Cancer. 2022 Feb;20(1):e7-e15. doi: 10.1016/j.clgc.2021.07.007. Epub 2021 Jul 10.
To evaluate the pattern of use of single-fraction conformal radiation therapy (SF-RT) and advanced radiation therapy techniques (ART), including stereotactic body radiation therapy (SBRT), for management of bone metastases (BM) in a population-based cohort of Australian men with prostate cancer (PCa) PATIENT AND METHODS: We reviewed men with metastatic PCa who received RT for BM between 2012 and 2017 as captured in the statewide Victorian Radiotherapy Minimum Data Set (VRMDS). The primary outcomes were: proportion of RT courses using SF-RT and ART. The Cochrane-Armitage test for trend was used to evaluate the changing pattern of SF-RT and ART over time. Multivariate analyses were used to identify factors associated with the primary outcomes RESULTS: Of the 4,324 courses of palliative RT for BM, 767 (17.7%) were SF-RT, and 615 (14.2%) were ART. There was no evidence of change in SF-RT use over time (P-trend=0.13). In multivariate analyses, increasing age at RT, site of BM (rib, shoulder, pelvis, and extremities), patients' area of residence (regional and remote), and treatment in public and metropolitan centres were associated with increased likelihood of SF-RT use. There was marked increase in ART use from 0.2% in 2012 to 24% in 2017 (11% intensity modulated RT, 13% SBRT) (P-trend<0.001). In multivariate analyses, younger age at RT, site of BM (rib and pelvis), higher socioeconomic status, and treatment in private and metropolitan centres were associated with increased likelihood of ART use.
SF-RT continues to be a clear minority of RT schedules employed in management of BM in PCa, and the adoption of SF-RT use should be encouraged in men with limited prognosis. There has been increasing use of ART, especially SBRT, for BM in PCa over time, and we expect this will continue to increase in the era of metastatic-directed treatment for PCa.
为了评估在澳大利亚前列腺癌(PCa)男性患者人群中,单次分割适形放射治疗(SF-RT)和高级放射治疗技术(ART),包括立体定向体放射治疗(SBRT),在治疗骨转移(BM)中的应用模式,我们回顾了 2012 年至 2017 年间在全州范围内维多利亚放射治疗最小数据集(VRMDS)中接受 RT 治疗 BM 的转移性 PCa 男性患者。主要结局为:使用 SF-RT 和 ART 的 RT 治疗方案的比例。采用 Cochrane-Armitage 趋势检验来评估 SF-RT 和 ART 随时间的变化模式。采用多变量分析来确定与主要结局相关的因素。
在 4324 例姑息性 BM 放疗中,767 例(17.7%)为 SF-RT,615 例(14.2%)为 ART。SF-RT 的使用并未随时间发生变化(趋势检验 P=0.13)。在多变量分析中,RT 时年龄较大、BM 部位(肋骨、肩部、骨盆和四肢)、患者居住地(区域和偏远地区)以及在公共和大都市中心接受治疗与 SF-RT 使用的可能性增加相关。ART 的使用从 2012 年的 0.2%显著增加到 2017 年的 24%(11%调强放疗,13% SBRT)(趋势检验 P<0.001)。在多变量分析中,RT 时年龄较小、BM 部位(肋骨和骨盆)、较高的社会经济地位以及在私立和大都市中心接受治疗与 ART 使用的可能性增加相关。
SF-RT 仍然是 PCa 中 BM 管理中 RT 方案的明显少数,对于预后有限的男性,应鼓励使用 SF-RT。随着时间的推移,ART,尤其是 SBRT,在 PCa 中的 BM 中的应用逐渐增加,我们预计在转移性 PCa 的定向治疗时代,这一趋势将继续增加。